       Document 0489
 DOCN  M9640489
 TI    Nosocomial tuberculosis: new progress in control and prevention.
 DT    9604
 AU    McGowan JE Jr; Department of Pathology, Emory University School of;
       Medicine/Grady Memorial Hospital, Atlanta, Georgia 30335, USA.
 SO    Clin Infect Dis. 1995 Sep;21(3):489-505. Unique Identifier : AIDSLINE
       MED/96077363
 AB    Nosocomial cases of tuberculosis have affected both health care workers
       and hospitalized patients, and each group has transmitted the infection
       to the other. This situation has been exacerbated by increases in the
       number of patients concurrently infected with human immunodeficiency
       virus and organisms resistant to multiple drugs; by inadequate
       implementation of procedures for the recognition, isolation, and
       treatment of patients with tuberculosis in health care and correctional
       facilities; and by a lack of practical engineering interventions for the
       control of airborne transmission. Epidemics at several hospitals have
       been controlled by the implementation of multiple measures listed in
       recent federal guidelines. Rapid recognition of cases and their
       effective isolation should be a priority at public hospitals, which can
       least afford the expensive engineering changes and personal respirators
       that are now mandated. Lacking are data on engineering controls
       (especially for retrofitting of existing facilities) and requirements
       for mask use that are both effective and financially practical. If
       relevant programs are to be developed, new methods are needed for the
       direct measurement of airborne transmission of tuberculosis.
       Fortunately, new federal guidelines allow individual hospitals and
       health care systems the flexibility to assess likely risk and to act in
       accordance with their findings to develop system-wide control programs.
 DE    AIDS-Related Opportunistic Infections/PREVENTION & CONTROL  Centers for
       Disease Control and Prevention (U.S.)  Community-Acquired
       Infections/PREVENTION & CONTROL/TRANSMISSION  Cross
       Infection/*PREVENTION & CONTROL/TRANSMISSION  Drug Resistance, Multiple
       Hospitals, Special  Human  HIV Infections/COMPLICATIONS  Mycobacterium
       tuberculosis/DRUG EFFECTS  Tuberculosis,
       Pulmonary/COMPLICATIONS/*PREVENTION & CONTROL/  TRANSMISSION  United
       States  JOURNAL ARTICLE  REVIEW  REVIEW, ACADEMIC

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

